Myovant Sciences Ltd. 4 SEC Filings

Filed On	Filing
10 Mar 2023	Form 4: Valente Nancy, Director Returned 3,673 shares to the issuer · Disposed of 36,892 Stock Options (Right to Buy) (Disposition to Issuer)
10 Mar 2023	Form 4: Potter Myrtle S, Director Returned 3,673 shares to the issuer · Disposed of 146,307 Stock Options (Right to Buy) (Disposition to Issuer)
10 Mar 2023	Form 4: Merendino Lauren, Chief Commercial Officer Returned 169,538 shares to the issuer · Disposed of 123,300 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 103,703 Performance Stock Unit (Disposition to Issuer)
10 Mar 2023	Form 4: Mehra Uneek, Principal Financial Officer Returned 202,696 shares to the issuer · Disposed of 165,192 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 111,111 Performance Stock Unit (Disposition to Issuer)
10 Mar 2023	Form 4: Marek David C, Director Returned 417,599 shares to the issuer · Disposed of 719,453 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 134,567 Performance Stock Unit (Disposition to Issuer)
10 Mar 2023	Form 4: Lang Matthew, General Counsel & Corp. Secy. Returned 354,303 shares to the issuer · Disposed of 719,866 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 111,111 Performance Stock Unit (Disposition to Issuer)
10 Mar 2023	Form 4: Gulfo Adele M., Director Returned 3,673 shares to the issuer · Disposed of 87,699 Stock Options (Right to Buy) (Disposition to Issuer)
10 Mar 2023	Form 4: Guinan Mark, Director Returned 3,673 shares to the issuer · Disposed of 146,307 Stock Options (Right to Buy) (Disposition to Issuer)
10 Mar 2023	Form 4: Curran Terrie, Director Returned 3,673 shares to the issuer · Disposed of 137,949 Stock Options (Right to Buy) (Disposition to Issuer)
10 Mar 2023	Form 4: Arjona Ferreira Juan Camilo, Chief Medical Officer Returned 246,684 shares to the issuer · Disposed of 498,816 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 103,703 Performance Stock Unit (Disposition to Issuer)
10 Mar 2023	Form 4: Sumitomo Chemical Co., Ltd., 10% owner and 2 others Bought 51,599,200 shares ($1.39B)
06 Mar 2023	Form 4: Sumitomo Chemical Co., Ltd., 10% owner and 2 others Disposed of 4,243,005 shares (Other Transaction) · Acquired 1 Option (Right to Acquire) (Other Transaction)
20 Jan 2023	Form 4: Lang Matthew, General Counsel & Corp. Secy. Sold 1,272 shares ($34.2K)
20 Jan 2023	Form 4: Merendino Lauren, Chief Commercial Officer Sold 2,008 shares ($54K)
20 Jan 2023	Form 4: Marek David C, Director Sold 8,037 shares ($216K)
20 Jan 2023	Form 4: Arjona Ferreira Juan Camilo, Chief Medical Officer Sold 1,109 shares ($29.8K)
05 Jan 2023	Form 4: Arjona Ferreira Juan Camilo, Chief Medical Officer Sold 2,251 shares ($60.6K)
05 Jan 2023	Form 4: Lang Matthew, General Counsel & Corp. Secy. Sold 2,779 shares ($74.8K)
20 Dec 2022	Form 4: Mehra Uneek, Principal Financial Officer Sold 2,241 shares ($59.9K)
28 Oct 2022	Form 4: Curran Terrie, Director Received 9,859 shares as a grant or award

Comments